Impact of the obesity epidemic on hypertension and renal disease.
about
Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysisThe Intricate Network of Adipokines and StrokeAnti-mullerian hormone as a predictor of time to menopause in late reproductive age womenLeptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study.The role of the sympathetic nervous system in obesity-related hypertensionBody size affects measures of ovarian reserve in late reproductive age women.Relationship between anthropometric measures and cardiovascular risk factors in children and adolescents.Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.Progression is accelerated from prehypertension to hypertension in blacksObesity and hypertension: two epidemics or one?Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese.Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.The pathophysiology of hypertension in patients with obesity.Obesity, metabolic syndrome and diabetic nephropathyAngiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.Obesity and diabetic kidney disease.Nonpharmacologic therapy for hypertension: does it really work?Renal denervation abolishes the age-dependent increase in blood pressure in female intrauterine growth-restricted rats at 12 months of ageAssociation of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's diseaseAdipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice.AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats.Obesity, hypertension, and chronic kidney disease.The role of sympathetic nervous activity in renal injury and end-stage renal disease.Orlistat and calcium oxalate crystalluria: an association that needs consideration.The role of angiotensin receptor blockers in diabetic nephropathy.Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials.Non-invasive blood pressure measurement: values, problems and applicability in the common marmoset (Callithrix jacchus).Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction.Kinetic analysis of cardiac transcriptome regulation during chronic high-fat diet in dogs.Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis.Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea.Evaluation of lipid profiles and hematological parameters in hypertensive patients: Laboratory-based cross-sectional study.
P2860
Q22242405-FD2F00D8-A609-4D03-99A1-B35115FC9D15Q26771261-B9EC706F-A2F4-4486-AB03-70752709ACADQ28383911-D34282C5-363E-44D3-94C6-61D0D798E40DQ33584896-14E5592B-8659-4233-91CA-A0E20D418C32Q33622500-28F15385-175C-4204-BBDC-241C5EBFE49DQ33653083-488D0DB0-F945-4914-9059-51C0E90465CBQ33773316-A71A302F-7889-4A46-B269-E5B961E57004Q33881270-E4E68E80-C080-44A3-A9F8-6802711289E5Q34215745-47A6F6FD-907E-4C98-9620-75658C67B177Q34311562-93168680-0916-47F4-867D-24922F575261Q34515571-839BD85B-2E21-432B-BC56-2AC4CDC99209Q34635250-E0950D0F-5F22-419A-8825-E28922B6EA29Q35021492-A4D72C78-D88B-4B48-9D70-949E91E5A809Q35224446-F0C2C8F3-6BE3-435E-9B62-8FFE1F8FD99CQ35749652-0FC95678-B4BA-4F53-999F-0092C495E50FQ36515043-B406DFA0-63FA-43E0-BD33-3918559AE0FBQ36632429-7203CE7E-24F9-4BE2-B5D8-361C580D1CD9Q36765690-F8100A94-1F59-4205-8CB7-6D027BDA115EQ36970053-B58AF0D8-D1EB-45D8-9548-AF58342A8CB2Q37298368-78A7BAB3-FC5A-403F-BE99-18D16B2B155CQ37551661-EBD8B4F8-FE5A-43D4-84EF-874946375E9EQ37601245-30F13BE3-49C2-4DB7-A4AD-095CFF0C439BQ37719241-C2137FC4-8F94-4DCB-93B5-760C51F89E65Q37781054-A4E88C35-1C01-44AB-9E73-C999E0B4FC74Q37874892-682BE8B4-49ED-47BB-8DD8-43CE26FD7D10Q38580775-D0FF1936-343B-4512-B7EB-6693FE5B726EQ41634709-C30D2AB4-08A3-4398-83B7-8707CF60AF7BQ45304577-141384A9-6A96-4AAA-823D-5D916B8A6AC6Q47264301-C4DAADAB-216D-4C0E-8A38-3F48C01BCFACQ47375496-3F510F9B-DD58-4B69-A749-CA2BD00901CFQ48508863-6398B2B6-BD16-40D7-A932-776725735821Q50146272-261C86BD-A1DB-47BD-92AE-F71A3C9E97A4
P2860
Impact of the obesity epidemic on hypertension and renal disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Impact of the obesity epidemic on hypertension and renal disease.
@ast
Impact of the obesity epidemic on hypertension and renal disease.
@en
Impact of the obesity epidemic on hypertension and renal disease.
@nl
type
label
Impact of the obesity epidemic on hypertension and renal disease.
@ast
Impact of the obesity epidemic on hypertension and renal disease.
@en
Impact of the obesity epidemic on hypertension and renal disease.
@nl
prefLabel
Impact of the obesity epidemic on hypertension and renal disease.
@ast
Impact of the obesity epidemic on hypertension and renal disease.
@en
Impact of the obesity epidemic on hypertension and renal disease.
@nl
P2093
P2860
P1476
Impact of the obesity epidemic on hypertension and renal disease.
@en
P2093
Daniel W Jones
Jiankang Liu
John E Hall
Lakshmi S Tallam
P2860
P2888
P304
P356
10.1007/S11906-003-0084-Z
P577
2003-10-01T00:00:00Z
P6179
1023911153